> top > docs > PubMed:25589620 > annotations

PubMed:25589620 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T6 812-958 Sentence denotes EXPERIMENTAL DESIGN: DNA from 746 stage II/III rectal patients enrolled in the Southwest Oncology Group (SWOG) S9304 phase III trial was analyzed.
T1 0-43 Sentence denotes Pharmacogenetic Analysis of INT 0144 Trial:
T2 44-158 Sentence denotes Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
T3 159-167 Sentence denotes PURPOSE:
T4 168-579 Sentence denotes We tested whether 18 polymorphisms in 16 genes (GSTP1, COX2, IL10, EGFR, EGF, FGFR4, CCDN1, VEGFR2, VEGF, CXCR2, IL8, MMP3, ICAM1, ERCC1, RAD51, and XRCC3) would predict disease-free survival (DFS), overall survival (OS), and toxicity in the INT0144 trial, which was designed to investigate different postoperative regimens of 5-fluorouracil (5-FU)-based chemoradiation (CRT) in locally advanced rectal cancers:
T5 580-811 Sentence denotes Arm 1 consisted of bolus 5-FU followed by 5-FU protracted venous infusion (PVI) with radiotherapy; arm 2 was induction and concomitant PVI 5-FU with radiotherapy and arm 3 was induction and concomitant bolus 5-FU with radiotherapy.
T7 959-1044 Sentence denotes Genomic DNA was extracted from formalin-fixed, paraffin-embedded (FFPE) tumor tissue.
T8 1045-1186 Sentence denotes The polymorphisms were analyzed using direct DNA-sequencing or polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
T9 1187-1311 Sentence denotes RESULTS: GSTP1-Ile105Val (rs1695) was significantly associated with DFS and OS and its effect did not vary by treatment arm.
T10 1312-1432 Sentence denotes The five-year DFS and OS were 53% and 58%, respectively, for G/G, 66% and 72% for G/A, and 57% and 66% for A/A patients.
T11 1433-1530 Sentence denotes In arm 2, IL8-251A/A genotype (rs4073) was associated with a lower risk of toxicities (P = 0.04).
T12 1531-1696 Sentence denotes The VEGFR2 H472Q Q/Q genotype (rs1870377) was associated with a higher risk of grade 3-5 proximal upper gastrointestinal tract (PUGIT) mucositis (P = 0.04) in arm 2.
T13 1697-1794 Sentence denotes However, in arm 1, this genotype was associated with a lower risk of PUGIT mucositis (P = 0.004).
T14 1795-1992 Sentence denotes CONCLUSION: rs1695 may be prognostic in patients with rectal cancer treated with adjuvant CRT. rs4073 and rs1870377 may exhibit different associations with toxicity, according to the 5-FU schedule.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
10429 91-99 DiseaseOrPhenotypicFeature denotes Toxicity MESH:D064420
10430 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer MESH:D012004
10431 117-125 OrganismTaxon denotes Patients NCBITaxon:9606
10432 139-143 ChemicalEntity denotes 5-FU MESH:D005472
10433 216-221 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
10434 223-227 GeneOrGeneProduct denotes COX2 NCBIGene:4513
10435 229-233 GeneOrGeneProduct denotes IL10 NCBIGene:3586
10436 235-239 GeneOrGeneProduct denotes EGFR NCBIGene:1956
10437 241-244 GeneOrGeneProduct denotes EGF NCBIGene:1950
10438 246-251 GeneOrGeneProduct denotes FGFR4 NCBIGene:2264
10439 253-258 GeneOrGeneProduct denotes CCDN1 NCBIGene:595
10440 260-266 GeneOrGeneProduct denotes VEGFR2 NCBIGene:3791
10441 268-272 GeneOrGeneProduct denotes VEGF NCBIGene:7422
10442 274-279 GeneOrGeneProduct denotes CXCR2 NCBIGene:3579
10443 281-284 GeneOrGeneProduct denotes IL8 NCBIGene:3576
10444 286-290 GeneOrGeneProduct denotes MMP3 NCBIGene:4314
10445 292-297 GeneOrGeneProduct denotes ICAM1 NCBIGene:3383
10446 299-304 GeneOrGeneProduct denotes ERCC1 NCBIGene:2067
10447 306-311 GeneOrGeneProduct denotes RAD51 NCBIGene:5888
10448 317-322 GeneOrGeneProduct denotes XRCC3 NCBIGene:7517
10449 394-402 DiseaseOrPhenotypicFeature denotes toxicity MESH:D064420
10450 495-509 ChemicalEntity denotes 5-fluorouracil MESH:D005472
10451 511-515 ChemicalEntity denotes 5-FU MESH:D005472
10452 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers MESH:D012004
10453 605-609 ChemicalEntity denotes 5-FU MESH:D005472
10454 622-626 ChemicalEntity denotes 5-FU MESH:D005472
10455 719-723 ChemicalEntity denotes 5-FU MESH:D005472
10456 788-792 ChemicalEntity denotes 5-FU MESH:D005472
10457 866-874 OrganismTaxon denotes patients NCBITaxon:9606
10458 990-998 ChemicalEntity denotes formalin MESH:D005557
10459 1006-1014 ChemicalEntity denotes paraffin MESH:D010232
10460 1031-1036 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
10461 1196-1201 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
10462 1202-1211 SequenceVariant denotes Ile105Val DBSNP:rs1695
10463 1213-1219 SequenceVariant denotes rs1695 DBSNP:rs1695
10464 1423-1431 OrganismTaxon denotes patients NCBITaxon:9606
10465 1443-1446 GeneOrGeneProduct denotes IL8 NCBIGene:3576
10466 1446-1453 SequenceVariant denotes -251A/A DBSNP:rs4073
10467 1464-1470 SequenceVariant denotes rs4073 DBSNP:rs4073
10468 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities MESH:D064420
10469 1535-1541 GeneOrGeneProduct denotes VEGFR2 NCBIGene:3791
10470 1542-1547 SequenceVariant denotes H472Q DBSNP:rs1870377
10471 1562-1571 SequenceVariant denotes rs1870377 DBSNP:rs1870377
10472 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis MESH:D052016
10473 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis MESH:D052016
10474 1807-1813 SequenceVariant denotes rs1695 DBSNP:rs1695
10475 1835-1843 OrganismTaxon denotes patients NCBITaxon:9606
10476 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer MESH:D012004
10477 1890-1896 SequenceVariant denotes rs4073 DBSNP:rs4073
10478 1901-1910 SequenceVariant denotes rs1870377 DBSNP:rs1870377
10479 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity MESH:D064420
10480 1978-1982 ChemicalEntity denotes 5-FU MESH:D005472

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer 0006519
T2 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers 0006519
T3 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis 0020579
T4 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis 0020579
T5 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer 0006519
T6 1856-1862 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 1202-1211 SequenceVariant denotes Ile105Val
T2 1213-1219 SequenceVariant denotes rs1695
T3 1446-1451 SequenceVariant denotes -251A
T4 1464-1470 SequenceVariant denotes rs4073
T5 1542-1547 SequenceVariant denotes H472Q
T6 1562-1571 SequenceVariant denotes rs1870377
T7 1807-1813 SequenceVariant denotes rs1695
T8 1890-1896 SequenceVariant denotes rs4073
T9 1901-1910 SequenceVariant denotes rs1870377

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 216-221 GeneOrGeneProduct denotes GSTP1
T2 223-227 GeneOrGeneProduct denotes COX2
T3 229-233 GeneOrGeneProduct denotes IL10
T4 235-239 GeneOrGeneProduct denotes EGFR
T5 246-251 GeneOrGeneProduct denotes FGFR4
T6 260-266 GeneOrGeneProduct denotes VEGFR2
T7 268-272 GeneOrGeneProduct denotes VEGF
T8 274-279 GeneOrGeneProduct denotes CXCR2
T9 281-284 GeneOrGeneProduct denotes IL8
T10 286-290 GeneOrGeneProduct denotes MMP3
T11 292-297 GeneOrGeneProduct denotes ICAM1
T12 299-304 GeneOrGeneProduct denotes ERCC1
T13 306-311 GeneOrGeneProduct denotes RAD51
T14 317-322 GeneOrGeneProduct denotes XRCC3
T15 580-585 GeneOrGeneProduct denotes Arm 1
T16 679-684 GeneOrGeneProduct denotes arm 2
T17 1108-1118 GeneOrGeneProduct denotes polymerase
T18 1119-1124 GeneOrGeneProduct denotes chain
T19 1196-1201 GeneOrGeneProduct denotes GSTP1
T20 1436-1441 GeneOrGeneProduct denotes arm 2
T21 1443-1446 GeneOrGeneProduct denotes IL8
T22 1535-1541 GeneOrGeneProduct denotes VEGFR2
T23 1690-1695 GeneOrGeneProduct denotes arm 2
T24 1709-1714 GeneOrGeneProduct denotes arm 1

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 28-31 GeneOrGeneProduct denotes INT
T2 171-177 GeneOrGeneProduct denotes tested
T3 203-208 GeneOrGeneProduct denotes in 16
T4 216-221 GeneOrGeneProduct denotes GSTP1
T5 223-227 GeneOrGeneProduct denotes COX2
T6 229-233 GeneOrGeneProduct denotes IL10
T7 235-239 GeneOrGeneProduct denotes EGFR
T8 246-251 GeneOrGeneProduct denotes FGFR4
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 268-272 GeneOrGeneProduct denotes VEGF
T11 274-279 GeneOrGeneProduct denotes CXCR2
T12 281-284 GeneOrGeneProduct denotes IL8
T13 286-290 GeneOrGeneProduct denotes MMP3
T14 292-297 GeneOrGeneProduct denotes ICAM1
T15 299-304 GeneOrGeneProduct denotes ERCC1
T16 306-311 GeneOrGeneProduct denotes RAD51
T17 317-322 GeneOrGeneProduct denotes XRCC3
T18 330-345 GeneOrGeneProduct denotes predict disease
T19 517-522 GeneOrGeneProduct denotes based
T20 580-585 GeneOrGeneProduct denotes Arm 1
T21 679-684 GeneOrGeneProduct denotes arm 2
T22 852-854 GeneOrGeneProduct denotes II
T23 855-858 GeneOrGeneProduct denotes III
T24 935-938 GeneOrGeneProduct denotes III
T25 1031-1036 GeneOrGeneProduct denotes tumor
T26 1108-1118 GeneOrGeneProduct denotes polymerase
T27 1119-1124 GeneOrGeneProduct denotes chain
T28 1180-1184 GeneOrGeneProduct denotes RFLP
T29 1196-1201 GeneOrGeneProduct denotes GSTP1
T30 1289-1293 GeneOrGeneProduct denotes vary
T31 1321-1325 GeneOrGeneProduct denotes year
T32 1386-1393 GeneOrGeneProduct denotes 72% for
T33 1411-1418 GeneOrGeneProduct denotes 66% for
T34 1436-1441 GeneOrGeneProduct denotes arm 2
T35 1443-1446 GeneOrGeneProduct denotes IL8
T36 1535-1541 GeneOrGeneProduct denotes VEGFR2
T37 1690-1695 GeneOrGeneProduct denotes arm 2
T38 1709-1714 GeneOrGeneProduct denotes arm 1

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T3 338-345 DiseaseOrPhenotypicFeature denotes disease D004194
T4 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T5 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T6 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T8 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T9 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T10 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 216-221 GeneOrGeneProduct denotes GSTP1
T2 223-227 GeneOrGeneProduct denotes COX2
T3 229-233 GeneOrGeneProduct denotes IL10
T4 235-239 GeneOrGeneProduct denotes EGFR
T5 246-251 GeneOrGeneProduct denotes FGFR4
T6 260-266 GeneOrGeneProduct denotes VEGFR2
T7 268-272 GeneOrGeneProduct denotes VEGF
T8 274-279 GeneOrGeneProduct denotes CXCR2
T9 281-284 GeneOrGeneProduct denotes IL8
T10 286-290 GeneOrGeneProduct denotes MMP3
T11 292-297 GeneOrGeneProduct denotes ICAM1
T12 299-304 GeneOrGeneProduct denotes ERCC1
T13 306-311 GeneOrGeneProduct denotes RAD51
T14 317-322 GeneOrGeneProduct denotes XRCC3
T15 580-585 GeneOrGeneProduct denotes Arm 1
T16 1196-1201 GeneOrGeneProduct denotes GSTP1
T17 1443-1446 GeneOrGeneProduct denotes IL8
T18 1535-1541 GeneOrGeneProduct denotes VEGFR2
T19 1709-1714 GeneOrGeneProduct denotes arm 1

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 1031-1036 DiseaseOrPhenotypicFeature denotes tumor 0005070
T2 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis 0020579|0000888
T4 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis 0020579|0000888
T6 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer 0044937|0006519

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T3 338-345 DiseaseOrPhenotypicFeature denotes disease D004194
T4 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T5 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T6 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T7 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities DISEASE
T8 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T9 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T10 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T11 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T3 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T4 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T5 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T6 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities DISEASE
T7 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T8 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T9 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T10 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 139-143 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T3 241-244 ChemicalEntity denotes EGF http://purl.obolibrary.org/obo/CHEBI_140739
T4 281-284 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T5 495-509 ChemicalEntity denotes 5-fluorouracil D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T7 511-515 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T9 605-609 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T11 622-626 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T13 719-723 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T15 788-792 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345
T17 990-998 ChemicalEntity denotes formalin D005557
T18 1006-1014 ChemicalEntity denotes paraffin D010232|ChemicalEntity
T20 1443-1446 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T21 1978-1982 ChemicalEntity denotes 5-FU D005472|http://purl.obolibrary.org/obo/CHEBI_46345

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 866-874 OrganismTaxon denotes patients
T2 1423-1431 OrganismTaxon denotes patients
T3 1835-1843 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T21 1978-1982 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T20 1443-1446 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T18 1006-1014 ChemicalEntity denotes paraffin ChemicalEntity|D010232
T17 990-998 ChemicalEntity denotes formalin D005557
T15 788-792 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T13 719-723 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T11 622-626 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T9 605-609 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T7 511-515 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T5 495-509 ChemicalEntity denotes 5-fluorouracil http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T4 281-284 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T3 241-244 ChemicalEntity denotes EGF http://purl.obolibrary.org/obo/CHEBI_140739
T1 139-143 ChemicalEntity denotes 5-FU http://purl.obolibrary.org/obo/CHEBI_46345|D005472
T19 1709-1714 GeneOrGeneProduct denotes arm 1
T44313 1535-1541 GeneOrGeneProduct denotes VEGFR2
T9341 1443-1446 GeneOrGeneProduct denotes IL8
T16 1196-1201 GeneOrGeneProduct denotes GSTP1
T11011 580-585 GeneOrGeneProduct denotes Arm 1
T14 317-322 GeneOrGeneProduct denotes XRCC3
T37430 306-311 GeneOrGeneProduct denotes RAD51
T12 299-304 GeneOrGeneProduct denotes ERCC1
T93406 292-297 GeneOrGeneProduct denotes ICAM1
T10 286-290 GeneOrGeneProduct denotes MMP3
T17644 281-284 GeneOrGeneProduct denotes IL8
T8 274-279 GeneOrGeneProduct denotes CXCR2
T8234 268-272 GeneOrGeneProduct denotes VEGF
T6 260-266 GeneOrGeneProduct denotes VEGFR2
T80266 246-251 GeneOrGeneProduct denotes FGFR4
T61221 235-239 GeneOrGeneProduct denotes EGFR
T66909 229-233 GeneOrGeneProduct denotes IL10
T2 223-227 GeneOrGeneProduct denotes COX2
T92556 216-221 GeneOrGeneProduct denotes GSTP1
T93010 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T10698 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer D012004
T46952 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis D052016
T90258 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis D052016
T14663 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities DISEASE
T45062 1031-1036 DiseaseOrPhenotypicFeature denotes tumor D009369
T90570 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers D012004
T52800 394-402 DiseaseOrPhenotypicFeature denotes toxicity DISEASE
T37712 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer D012004
T84313 91-99 DiseaseOrPhenotypicFeature denotes Toxicity DISEASE
T79210 1835-1843 OrganismTaxon denotes patients
T32207 1423-1431 OrganismTaxon denotes patients
T81674 866-874 OrganismTaxon denotes patients
T11383 1901-1910 SequenceVariant denotes rs1870377
T47744 1890-1896 SequenceVariant denotes rs4073
T63948 1807-1813 SequenceVariant denotes rs1695
T7172 1562-1571 SequenceVariant denotes rs1870377
T47503 1542-1547 SequenceVariant denotes H472Q
T69073 1464-1470 SequenceVariant denotes rs4073
T50845 1446-1451 SequenceVariant denotes -251A
T76587 1213-1219 SequenceVariant denotes rs1695
T87977 1202-1211 SequenceVariant denotes Ile105Val

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 571-578 HP_0002664 denotes cancers

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
25589620-10#94#103#geners1870377 1901-1910 geners1870377 denotes rs1870377
25589620-10#0#6#geners1695 1807-1813 geners1695 denotes rs1695
25589620-10#78#81#diseaseC1559154 1885-1888 diseaseC1559154 denotes CRT
25589620-10#42#55#diseaseC0007113 1849-1862 diseaseC0007113 denotes rectal cancer
25589620-10#78#81#diseaseC1559154 1885-1888 diseaseC1559154 denotes CRT
25589620-8#31#40#geners1870377 1562-1571 geners1870377 denotes rs1870377
25589620-8#11#16#geners1870377 1542-1547 geners1870377 denotes H472Q
25589620-8#135#144#diseaseC0521585 1666-1675 diseaseC0521585 denotes mucositis
94#103#geners187037778#81#diseaseC1559154 25589620-10#94#103#geners1870377 25589620-10#78#81#diseaseC1559154 associated_with rs1870377,CRT
94#103#geners187037742#55#diseaseC0007113 25589620-10#94#103#geners1870377 25589620-10#42#55#diseaseC0007113 associated_with rs1870377,rectal cancer
94#103#geners187037778#81#diseaseC1559154 25589620-10#94#103#geners1870377 25589620-10#78#81#diseaseC1559154 associated_with rs1870377,CRT
0#6#geners169578#81#diseaseC1559154 25589620-10#0#6#geners1695 25589620-10#78#81#diseaseC1559154 associated_with rs1695,CRT
0#6#geners169542#55#diseaseC0007113 25589620-10#0#6#geners1695 25589620-10#42#55#diseaseC0007113 associated_with rs1695,rectal cancer
0#6#geners169578#81#diseaseC1559154 25589620-10#0#6#geners1695 25589620-10#78#81#diseaseC1559154 associated_with rs1695,CRT
31#40#geners1870377135#144#diseaseC0521585 25589620-8#31#40#geners1870377 25589620-8#135#144#diseaseC0521585 associated_with rs1870377,mucositis
11#16#geners1870377135#144#diseaseC0521585 25589620-8#11#16#geners1870377 25589620-8#135#144#diseaseC0521585 associated_with H472Q,mucositis

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
25589620-0#28#31#gene27152 28-31 gene27152 denotes INT
25589620-0#103#116#diseaseC0007113 103-116 diseaseC0007113 denotes Rectal Cancer
25589620-1#412#417#gene11047 580-585 gene11047 denotes Arm 1
25589620-1#412#417#gene9622 580-585 gene9622 denotes Arm 1
25589620-1#412#417#gene11047 580-585 gene11047 denotes Arm 1
25589620-1#412#417#gene9622 580-585 gene9622 denotes Arm 1
25589620-1#412#417#gene11047 580-585 gene11047 denotes Arm 1
25589620-1#412#417#gene9622 580-585 gene9622 denotes Arm 1
25589620-1#149#154#gene7517 317-322 gene7517 denotes XRCC3
25589620-1#355#369#diseaseC1559154 523-537 diseaseC1559154 denotes chemoradiation
25589620-1#371#374#diseaseC1559154 539-542 diseaseC1559154 denotes CRT
25589620-1#396#410#diseaseC0007113 564-578 diseaseC0007113 denotes rectal cancers
25589620-1#355#369#diseaseC1559154 523-537 diseaseC1559154 denotes chemoradiation
25589620-1#371#374#diseaseC1559154 539-542 diseaseC1559154 denotes CRT
25589620-1#396#410#diseaseC0007113 564-578 diseaseC0007113 denotes rectal cancers
25589620-8#4#10#gene3791 1535-1541 gene3791 denotes VEGFR2
25589620-8#135#144#diseaseC0521585 1666-1675 diseaseC0521585 denotes mucositis
28#31#gene27152103#116#diseaseC0007113 25589620-0#28#31#gene27152 25589620-0#103#116#diseaseC0007113 associated_with INT,Rectal Cancer
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene11047355#369#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene11047371#374#diseaseC1559154 25589620-1#412#417#gene11047 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene11047396#410#diseaseC0007113 25589620-1#412#417#gene11047 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
412#417#gene9622355#369#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#355#369#diseaseC1559154 associated_with Arm 1,chemoradiation
412#417#gene9622371#374#diseaseC1559154 25589620-1#412#417#gene9622 25589620-1#371#374#diseaseC1559154 associated_with Arm 1,CRT
412#417#gene9622396#410#diseaseC0007113 25589620-1#412#417#gene9622 25589620-1#396#410#diseaseC0007113 associated_with Arm 1,rectal cancers
149#154#gene7517355#369#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#355#369#diseaseC1559154 associated_with XRCC3,chemoradiation
149#154#gene7517371#374#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#371#374#diseaseC1559154 associated_with XRCC3,CRT
149#154#gene7517396#410#diseaseC0007113 25589620-1#149#154#gene7517 25589620-1#396#410#diseaseC0007113 associated_with XRCC3,rectal cancers
149#154#gene7517355#369#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#355#369#diseaseC1559154 associated_with XRCC3,chemoradiation
149#154#gene7517371#374#diseaseC1559154 25589620-1#149#154#gene7517 25589620-1#371#374#diseaseC1559154 associated_with XRCC3,CRT
149#154#gene7517396#410#diseaseC0007113 25589620-1#149#154#gene7517 25589620-1#396#410#diseaseC0007113 associated_with XRCC3,rectal cancers
4#10#gene3791135#144#diseaseC0521585 25589620-8#4#10#gene3791 25589620-8#135#144#diseaseC0521585 associated_with VEGFR2,mucositis

biored-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 28-36 SequenceVariant denotes INT 0144
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 511-515 ChemicalEntity denotes 5-FU
T18 788-792 ChemicalEntity denotes 5-FU
T19 917-921 SequenceVariant denotes SWOG
T20 923-928 SequenceVariant denotes S9304
T21 1025-1029 SequenceVariant denotes FFPE
T22 1176-1184 SequenceVariant denotes PCR-RFLP
T23 1196-1211 GeneOrGeneProduct denotes GSTP1-Ile105Val
T24 1213-1219 SequenceVariant denotes rs1695
T25 1443-1453 GeneOrGeneProduct denotes IL8-251A/A
T26 1464-1470 SequenceVariant denotes rs4073
T27 1542-1551 SequenceVariant denotes H472Q Q/Q
T28 1562-1571 SequenceVariant denotes rs1870377

biored-valid

Id Subject Object Predicate Lexical cue
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T3 117-125 OrganismTaxon denotes Patients
T4 139-143 ChemicalEntity denotes 5-FU
T5 216-221 GeneOrGeneProduct denotes GSTP1
T6 223-227 GeneOrGeneProduct denotes COX2
T7 229-233 GeneOrGeneProduct denotes IL10
T8 235-239 GeneOrGeneProduct denotes EGFR
T9 241-244 GeneOrGeneProduct denotes EGF
T10 246-251 GeneOrGeneProduct denotes FGFR4
T11 253-258 GeneOrGeneProduct denotes CCDN1
T12 260-266 GeneOrGeneProduct denotes VEGFR2
T13 268-272 GeneOrGeneProduct denotes VEGF
T14 274-279 GeneOrGeneProduct denotes CXCR2
T15 281-284 GeneOrGeneProduct denotes IL8
T16 286-290 GeneOrGeneProduct denotes MMP3
T17 292-297 GeneOrGeneProduct denotes ICAM1
T18 299-304 GeneOrGeneProduct denotes ERCC1
T19 306-311 GeneOrGeneProduct denotes RAD51
T20 317-322 GeneOrGeneProduct denotes XRCC3
T21 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T22 495-509 ChemicalEntity denotes 5-fluorouracil
T23 511-515 ChemicalEntity denotes 5-FU
T24 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T25 605-609 ChemicalEntity denotes 5-FU
T26 622-626 ChemicalEntity denotes 5-FU
T27 719-723 ChemicalEntity denotes 5-FU
T28 788-792 ChemicalEntity denotes 5-FU
T29 866-874 OrganismTaxon denotes patients
T30 990-998 ChemicalEntity denotes formalin
T31 1006-1014 ChemicalEntity denotes paraffin
T32 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T33 1196-1201 GeneOrGeneProduct denotes GSTP1
T34 1202-1211 SequenceVariant denotes Ile105Val
T35 1213-1219 SequenceVariant denotes rs1695
T36 1423-1431 OrganismTaxon denotes patients
T37 1443-1446 GeneOrGeneProduct denotes IL8
T38 1446-1453 SequenceVariant denotes -251A/A
T39 1464-1470 SequenceVariant denotes rs4073
T40 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T41 1535-1541 GeneOrGeneProduct denotes VEGFR2
T42 1542-1547 SequenceVariant denotes H472Q
T43 1562-1571 SequenceVariant denotes rs1870377
T44 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T45 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis
T46 1807-1813 SequenceVariant denotes rs1695
T47 1835-1843 OrganismTaxon denotes patients
T48 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T49 1890-1896 SequenceVariant denotes rs4073
T50 1901-1910 SequenceVariant denotes rs1870377
T51 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T52 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 0-15 GeneOrGeneProduct denotes Pharmacogenetic
T2 16-24 GeneOrGeneProduct denotes Analysis
T3 28-36 DiseaseOrPhenotypicFeature denotes INT 0144
T4 37-43 DiseaseOrPhenotypicFeature denotes Trial:
T5 44-72 SequenceVariant denotes Association of Polymorphisms
T6 73-86 DiseaseOrPhenotypicFeature denotes with Survival
T7 87-99 DiseaseOrPhenotypicFeature denotes and Toxicity
T8 100-125 DiseaseOrPhenotypicFeature denotes in Rectal Cancer Patients
T9 126-138 DiseaseOrPhenotypicFeature denotes Treated with
T10 139-143 ChemicalEntity denotes 5-FU
T11 144-158 DiseaseOrPhenotypicFeature denotes and Radiation.
T12 159-167 DiseaseOrPhenotypicFeature denotes PURPOSE:
T13 168-177 DiseaseOrPhenotypicFeature denotes We tested
T14 178-185 DiseaseOrPhenotypicFeature denotes whether
T15 186-188 SequenceVariant denotes 18
T16 189-205 SequenceVariant denotes polymorphisms in
T17 206-208 GeneOrGeneProduct denotes 16
T18 209-214 GeneOrGeneProduct denotes genes
T19 215-222 GeneOrGeneProduct denotes (GSTP1,
T20 223-228 GeneOrGeneProduct denotes COX2,
T21 229-234 GeneOrGeneProduct denotes IL10,
T22 235-240 GeneOrGeneProduct denotes EGFR,
T23 241-245 GeneOrGeneProduct denotes EGF,
T24 246-252 GeneOrGeneProduct denotes FGFR4,
T25 253-259 GeneOrGeneProduct denotes CCDN1,
T26 260-267 GeneOrGeneProduct denotes VEGFR2,
T27 268-273 GeneOrGeneProduct denotes VEGF,
T28 274-280 GeneOrGeneProduct denotes CXCR2,
T29 281-285 GeneOrGeneProduct denotes IL8,
T30 286-291 GeneOrGeneProduct denotes MMP3,
T31 292-298 GeneOrGeneProduct denotes ICAM1,
T32 299-305 GeneOrGeneProduct denotes ERCC1,
T33 306-312 GeneOrGeneProduct denotes RAD51,
T34 313-323 GeneOrGeneProduct denotes and XRCC3)
T35 324-337 DiseaseOrPhenotypicFeature denotes would predict
T36 338-359 DiseaseOrPhenotypicFeature denotes disease-free survival
T37 360-366 DiseaseOrPhenotypicFeature denotes (DFS),
T38 367-383 DiseaseOrPhenotypicFeature denotes overall survival
T39 384-389 DiseaseOrPhenotypicFeature denotes (OS),
T40 390-402 DiseaseOrPhenotypicFeature denotes and toxicity
T41 403-417 DiseaseOrPhenotypicFeature denotes in the INT0144
T42 418-424 DiseaseOrPhenotypicFeature denotes trial,
T43 425-434 DiseaseOrPhenotypicFeature denotes which was
T44 435-446 DiseaseOrPhenotypicFeature denotes designed to
T45 447-458 DiseaseOrPhenotypicFeature denotes investigate
T46 459-468 DiseaseOrPhenotypicFeature denotes different
T47 469-482 DiseaseOrPhenotypicFeature denotes postoperative
T48 483-494 DiseaseOrPhenotypicFeature denotes regimens of
T49 511-515 ChemicalEntity denotes 5-FU
T50 516-522 ChemicalEntity denotes -based
T51 523-537 DiseaseOrPhenotypicFeature denotes chemoradiation
T52 538-543 DiseaseOrPhenotypicFeature denotes (CRT)
T53 544-563 DiseaseOrPhenotypicFeature denotes in locally advanced
T54 564-579 DiseaseOrPhenotypicFeature denotes rectal cancers:
T55 580-585 DiseaseOrPhenotypicFeature denotes Arm 1
T56 586-598 DiseaseOrPhenotypicFeature denotes consisted of
T57 599-604 ChemicalEntity denotes bolus
T58 605-609 ChemicalEntity denotes 5-FU
T59 610-621 DiseaseOrPhenotypicFeature denotes followed by
T60 622-626 ChemicalEntity denotes 5-FU
T61 627-653 DiseaseOrPhenotypicFeature denotes protracted venous infusion
T62 654-659 DiseaseOrPhenotypicFeature denotes (PVI)
T63 660-664 DiseaseOrPhenotypicFeature denotes with
T64 665-678 DiseaseOrPhenotypicFeature denotes radiotherapy;
T65 679-684 DiseaseOrPhenotypicFeature denotes arm 2
T66 685-688 DiseaseOrPhenotypicFeature denotes was
T67 689-702 DiseaseOrPhenotypicFeature denotes induction and
T68 703-714 DiseaseOrPhenotypicFeature denotes concomitant
T69 750-751 DiseaseOrPhenotypicFeature denotes 3
T70 752-755 GeneOrGeneProduct denotes was
T71 798-811 DiseaseOrPhenotypicFeature denotes radiotherapy.
T72 812-832 DiseaseOrPhenotypicFeature denotes EXPERIMENTAL DESIGN:
T73 833-836 GeneOrGeneProduct denotes DNA
T74 837-845 GeneOrGeneProduct denotes from 746
T75 846-854 DiseaseOrPhenotypicFeature denotes stage II
T76 854-858 DiseaseOrPhenotypicFeature denotes /III
T77 859-865 DiseaseOrPhenotypicFeature denotes rectal
T78 866-874 DiseaseOrPhenotypicFeature denotes patients
T79 875-886 DiseaseOrPhenotypicFeature denotes enrolled in
T80 887-900 DiseaseOrPhenotypicFeature denotes the Southwest
T81 901-915 DiseaseOrPhenotypicFeature denotes Oncology Group
T82 916-922 DiseaseOrPhenotypicFeature denotes (SWOG)
T83 923-928 DiseaseOrPhenotypicFeature denotes S9304
T84 929-938 DiseaseOrPhenotypicFeature denotes phase III
T85 939-948 DiseaseOrPhenotypicFeature denotes trial was
T86 949-958 DiseaseOrPhenotypicFeature denotes analyzed.
T87 959-970 GeneOrGeneProduct denotes Genomic DNA
T88 971-974 SequenceVariant denotes was
T89 975-989 GeneOrGeneProduct denotes extracted from
T90 990-1005 ChemicalEntity denotes formalin-fixed,
T91 1006-1023 ChemicalEntity denotes paraffin-embedded
T92 1024-1030 ChemicalEntity denotes (FFPE)
T93 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T94 1037-1044 DiseaseOrPhenotypicFeature denotes tissue.
T95 1045-1048 SequenceVariant denotes The
T96 1049-1067 SequenceVariant denotes polymorphisms were
T97 1068-1082 SequenceVariant denotes analyzed using
T98 1083-1089 SequenceVariant denotes direct
T99 1093-1107 GeneOrGeneProduct denotes -sequencing or
T100 1108-1118 GeneOrGeneProduct denotes polymerase
T101 1119-1133 GeneOrGeneProduct denotes chain reaction
T102 1133-1145 GeneOrGeneProduct denotes -restriction
T103 1146-1161 GeneOrGeneProduct denotes fragment length
T104 1175-1186 SequenceVariant denotes (PCR-RFLP).
T105 1187-1195 DiseaseOrPhenotypicFeature denotes RESULTS:
T106 1196-1201 GeneOrGeneProduct denotes GSTP1
T107 1201-1220 SequenceVariant denotes -Ile105Val (rs1695)
T108 1221-1224 SequenceVariant denotes was
T109 1225-1238 SequenceVariant denotes significantly
T110 1239-1254 SequenceVariant denotes associated with
T111 1255-1258 DiseaseOrPhenotypicFeature denotes DFS
T112 1259-1265 DiseaseOrPhenotypicFeature denotes and OS
T113 1270-1280 SequenceVariant denotes its effect
T114 1281-1284 SequenceVariant denotes did
T115 1285-1288 SequenceVariant denotes not
T116 1289-1296 SequenceVariant denotes vary by
T117 1297-1311 SequenceVariant denotes treatment arm.
T118 1312-1315 GeneOrGeneProduct denotes The
T119 1316-1325 DiseaseOrPhenotypicFeature denotes five-year
T120 1342-1345 DiseaseOrPhenotypicFeature denotes 53%
T121 1346-1354 DiseaseOrPhenotypicFeature denotes and 58%,
T122 1355-1368 DiseaseOrPhenotypicFeature denotes respectively,
T123 1373-1377 SequenceVariant denotes G/G,
T124 1378-1385 DiseaseOrPhenotypicFeature denotes 66% and
T125 1386-1393 DiseaseOrPhenotypicFeature denotes 72% for
T126 1394-1398 SequenceVariant denotes G/A,
T127 1399-1406 DiseaseOrPhenotypicFeature denotes and 57%
T128 1407-1414 DiseaseOrPhenotypicFeature denotes and 66%
T129 1415-1422 SequenceVariant denotes for A/A
T130 1423-1432 DiseaseOrPhenotypicFeature denotes patients.
T131 1433-1435 DiseaseOrPhenotypicFeature denotes In
T132 1436-1442 DiseaseOrPhenotypicFeature denotes arm 2,
T133 1443-1446 GeneOrGeneProduct denotes IL8
T134 1446-1462 SequenceVariant denotes -251A/A genotype
T135 1463-1475 SequenceVariant denotes (rs4073) was
T136 1476-1491 SequenceVariant denotes associated with
T137 1492-1499 SequenceVariant denotes a lower
T138 1500-1507 SequenceVariant denotes risk of
T139 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T140 1519-1530 DiseaseOrPhenotypicFeature denotes (P = 0.04).
T141 1535-1541 GeneOrGeneProduct denotes VEGFR2
T142 1542-1551 SequenceVariant denotes H472Q Q/Q
T143 1561-1572 SequenceVariant denotes (rs1870377)
T144 1593-1601 SequenceVariant denotes a higher
T145 1610-1619 DiseaseOrPhenotypicFeature denotes grade 3-5
T146 1620-1634 DiseaseOrPhenotypicFeature denotes proximal upper
T147 1635-1651 DiseaseOrPhenotypicFeature denotes gastrointestinal
T148 1652-1657 DiseaseOrPhenotypicFeature denotes tract
T149 1658-1665 DiseaseOrPhenotypicFeature denotes (PUGIT)
T150 1666-1680 DiseaseOrPhenotypicFeature denotes mucositis (P =
T151 1681-1689 DiseaseOrPhenotypicFeature denotes 0.04) in
T152 1690-1696 DiseaseOrPhenotypicFeature denotes arm 2.
T153 1697-1708 DiseaseOrPhenotypicFeature denotes However, in
T154 1709-1715 DiseaseOrPhenotypicFeature denotes arm 1,
T155 1716-1720 SequenceVariant denotes this
T156 1721-1733 SequenceVariant denotes genotype was
T157 1787-1794 DiseaseOrPhenotypicFeature denotes 0.004).
T158 1795-1806 DiseaseOrPhenotypicFeature denotes CONCLUSION:
T159 1814-1817 SequenceVariant denotes may
T160 1818-1820 SequenceVariant denotes be
T161 1821-1834 SequenceVariant denotes prognostic in
T162 1835-1848 SequenceVariant denotes patients with
T163 1849-1855 DiseaseOrPhenotypicFeature denotes rectal
T164 1856-1862 DiseaseOrPhenotypicFeature denotes cancer
T165 1863-1875 DiseaseOrPhenotypicFeature denotes treated with
T166 1876-1889 DiseaseOrPhenotypicFeature denotes adjuvant CRT.
T167 1897-1910 SequenceVariant denotes and rs1870377
T168 1915-1932 SequenceVariant denotes exhibit different
T169 1933-1950 SequenceVariant denotes associations with
T170 1951-1960 DiseaseOrPhenotypicFeature denotes toxicity,
T171 1961-1973 DiseaseOrPhenotypicFeature denotes according to
T172 1974-1982 ChemicalEntity denotes the 5-FU
T173 1983-1992 ChemicalEntity denotes schedule.

biored-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 148-157 ChemicalEntity denotes Radiation
T4 216-221 GeneOrGeneProduct denotes GSTP1
T5 223-227 GeneOrGeneProduct denotes COX2
T6 229-233 GeneOrGeneProduct denotes IL10
T7 235-239 GeneOrGeneProduct denotes EGFR
T8 246-251 GeneOrGeneProduct denotes FGFR4
T9 253-258 GeneOrGeneProduct denotes CCDN1
T10 260-266 GeneOrGeneProduct denotes VEGFR2
T11 274-279 GeneOrGeneProduct denotes CXCR2
T12 281-284 GeneOrGeneProduct denotes IL8
T13 286-290 GeneOrGeneProduct denotes MMP3
T14 292-297 GeneOrGeneProduct denotes ICAM1
T15 299-304 GeneOrGeneProduct denotes ERCC1
T16 306-311 GeneOrGeneProduct denotes RAD51
T17 317-322 GeneOrGeneProduct denotes XRCC3
T18 338-359 DiseaseOrPhenotypicFeature denotes disease-free survival
T19 361-364 DiseaseOrPhenotypicFeature denotes DFS
T20 367-383 DiseaseOrPhenotypicFeature denotes overall survival
T21 385-387 DiseaseOrPhenotypicFeature denotes OS
T22 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T23 495-509 ChemicalEntity denotes 5-fluorouracil
T24 511-515 ChemicalEntity denotes 5-FU
T25 523-537 ChemicalEntity denotes chemoradiation
T26 539-542 ChemicalEntity denotes CRT
T27 547-578 DiseaseOrPhenotypicFeature denotes locally advanced rectal cancers
T28 605-609 ChemicalEntity denotes 5-FU
T29 833-836 ChemicalEntity denotes DNA
T30 959-970 ChemicalEntity denotes Genomic DNA
T31 990-998 ChemicalEntity denotes formalin
T32 1006-1014 ChemicalEntity denotes paraffin
T33 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T34 1213-1219 SequenceVariant denotes rs1695
T35 1255-1258 DiseaseOrPhenotypicFeature denotes DFS
T36 1263-1265 DiseaseOrPhenotypicFeature denotes OS
T37 1373-1376 SequenceVariant denotes G/G
T38 1394-1397 SequenceVariant denotes G/A
T39 1419-1422 SequenceVariant denotes A/A
T40 1443-1453 SequenceVariant denotes IL8-251A/A
T41 1464-1470 SequenceVariant denotes rs4073
T42 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T43 1535-1551 SequenceVariant denotes VEGFR2 H472Q Q/Q
T44 1562-1571 SequenceVariant denotes rs1870377
T45 1766-1781 DiseaseOrPhenotypicFeature denotes PUGIT mucositis
T46 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T18 495-509 ChemicalEntity denotes 5-fluorouracil
T19 511-515 ChemicalEntity denotes 5-FU
T20 833-836 ChemicalEntity denotes DNA
T21 990-998 ChemicalEntity denotes formalin
T22 1006-1014 ChemicalEntity denotes paraffin
T23 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T24 1213-1219 SequenceVariant denotes rs1695
T25 1443-1453 SequenceVariant denotes IL8-251A/A
T26 1464-1470 SequenceVariant denotes rs4073
T27 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T28 1535-1547 SequenceVariant denotes VEGFR2 H472Q
T29 1562-1571 SequenceVariant denotes rs1870377
T30 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis

biored-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 59-72 SequenceVariant denotes Polymorphisms
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T3 139-143 ChemicalEntity denotes 5-FU
T4 189-202 SequenceVariant denotes polymorphisms
T5 209-214 GeneOrGeneProduct denotes genes
T6 216-221 GeneOrGeneProduct denotes GSTP1
T7 223-227 GeneOrGeneProduct denotes COX2
T8 229-233 GeneOrGeneProduct denotes IL10
T9 235-239 GeneOrGeneProduct denotes EGFR
T10 246-251 GeneOrGeneProduct denotes FGFR4
T11 253-258 GeneOrGeneProduct denotes CCDN1
T12 260-266 GeneOrGeneProduct denotes VEGFR2
T13 274-279 GeneOrGeneProduct denotes CXCR2
T14 281-284 GeneOrGeneProduct denotes IL8
T15 286-290 GeneOrGeneProduct denotes MMP3
T16 292-297 GeneOrGeneProduct denotes ICAM1
T17 299-304 GeneOrGeneProduct denotes ERCC1
T18 306-311 GeneOrGeneProduct denotes RAD51
T19 317-322 GeneOrGeneProduct denotes XRCC3
T20 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T21 495-509 ChemicalEntity denotes 5-fluorouracil
T22 511-515 ChemicalEntity denotes 5-FU
T23 571-578 DiseaseOrPhenotypicFeature denotes cancers
T24 605-609 ChemicalEntity denotes 5-FU
T25 719-723 ChemicalEntity denotes 5-FU
T26 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T27 1049-1062 SequenceVariant denotes polymorphisms
T28 1196-1201 GeneOrGeneProduct denotes GSTP1
T29 1202-1211 SequenceVariant denotes Ile105Val
T30 1213-1219 SequenceVariant denotes rs1695
T31 1443-1446 GeneOrGeneProduct denotes IL8
T32 1446-1462 SequenceVariant denotes -251A/A genotype
T33 1464-1470 SequenceVariant denotes rs4073
T34 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T35 1535-1541 GeneOrGeneProduct denotes VEGFR2
T36 1542-1560 SequenceVariant denotes H472Q Q/Q genotype
T37 1562-1571 SequenceVariant denotes rs1870377
T38 1620-1675 DiseaseOrPhenotypicFeature denotes proximal upper gastrointestinal tract (PUGIT) mucositis
T39 1766-1781 DiseaseOrPhenotypicFeature denotes PUGIT mucositis
T40 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T41 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T42 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 338-359 DiseaseOrPhenotypicFeature denotes disease-free survival
T18 361-364 DiseaseOrPhenotypicFeature denotes DFS
T19 367-383 DiseaseOrPhenotypicFeature denotes overall survival
T20 385-387 DiseaseOrPhenotypicFeature denotes OS
T21 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T22 495-509 ChemicalEntity denotes 5-fluorouracil
T23 511-515 ChemicalEntity denotes 5-FU
T24 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T25 605-609 ChemicalEntity denotes 5-FU
T26 622-626 ChemicalEntity denotes 5-FU
T27 719-723 ChemicalEntity denotes 5-FU
T28 833-836 ChemicalEntity denotes DNA
T29 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T30 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T31 1213-1219 SequenceVariant denotes rs1695
T32 1255-1258 DiseaseOrPhenotypicFeature denotes DFS
T33 1263-1265 DiseaseOrPhenotypicFeature denotes OS
T34 1373-1376 SequenceVariant denotes G/G
T35 1394-1397 SequenceVariant denotes G/A
T36 1419-1422 SequenceVariant denotes A/A
T37 1443-1462 SequenceVariant denotes IL8-251A/A genotype
T38 1464-1470 SequenceVariant denotes rs4073
T39 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T40 1535-1547 SequenceVariant denotes VEGFR2 H472Q
T41 1548-1551 SequenceVariant denotes Q/Q
T42 1562-1571 SequenceVariant denotes rs1870377
T43 1610-1675 DiseaseOrPhenotypicFeature denotes grade 3-5 proximal upper gastrointestinal tract (PUGIT) mucositis
T44 1766-1781 DiseaseOrPhenotypicFeature denotes PUGIT mucositis
T45 1807-1813 SequenceVariant denotes rs1695
T46 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T47 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T48 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T3 139-143 ChemicalEntity denotes 5-FU
T4 216-221 GeneOrGeneProduct denotes GSTP1
T5 223-227 GeneOrGeneProduct denotes COX2
T6 229-233 GeneOrGeneProduct denotes IL10
T7 235-239 GeneOrGeneProduct denotes EGFR
T8 246-251 GeneOrGeneProduct denotes FGFR4
T9 253-258 GeneOrGeneProduct denotes CCDN1
T10 260-266 GeneOrGeneProduct denotes VEGFR2
T11 274-279 GeneOrGeneProduct denotes CXCR2
T12 281-284 GeneOrGeneProduct denotes IL8
T13 286-290 GeneOrGeneProduct denotes MMP3
T14 292-297 GeneOrGeneProduct denotes ICAM1
T15 299-304 GeneOrGeneProduct denotes ERCC1
T16 306-311 GeneOrGeneProduct denotes RAD51
T17 317-322 GeneOrGeneProduct denotes XRCC3
T18 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T19 495-509 ChemicalEntity denotes 5-fluorouracil
T20 511-515 ChemicalEntity denotes 5-FU
T21 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T22 605-609 ChemicalEntity denotes 5-FU
T23 719-723 ChemicalEntity denotes 5-FU
T24 859-865 DiseaseOrPhenotypicFeature denotes rectal
T25 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T26 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T27 1213-1219 SequenceVariant denotes rs1695
T28 1443-1453 SequenceVariant denotes IL8-251A/A
T29 1464-1470 SequenceVariant denotes rs4073
T30 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T31 1535-1547 SequenceVariant denotes VEGFR2 H472Q
T32 1562-1571 SequenceVariant denotes rs1870377
T33 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T34 1807-1813 SequenceVariant denotes rs1695
T35 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T36 1890-1896 SequenceVariant denotes rs4073
T37 1901-1910 SequenceVariant denotes rs1870377
T38 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T39 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 338-359 DiseaseOrPhenotypicFeature denotes disease-free survival
T18 367-383 DiseaseOrPhenotypicFeature denotes overall survival
T19 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T20 495-509 ChemicalEntity denotes 5-fluorouracil
T21 511-515 ChemicalEntity denotes 5-FU
T22 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T23 605-609 ChemicalEntity denotes 5-FU
T24 719-723 ChemicalEntity denotes 5-FU
T25 788-792 ChemicalEntity denotes 5-FU
T26 833-836 ChemicalEntity denotes DNA
T27 967-970 ChemicalEntity denotes DNA
T28 990-998 ChemicalEntity denotes formalin
T29 1006-1014 ChemicalEntity denotes paraffin
T30 1090-1093 ChemicalEntity denotes DNA
T31 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T32 1213-1219 SequenceVariant denotes rs1695
T33 1255-1258 DiseaseOrPhenotypicFeature denotes DFS
T34 1263-1265 DiseaseOrPhenotypicFeature denotes OS
T35 1326-1329 DiseaseOrPhenotypicFeature denotes DFS
T36 1334-1336 DiseaseOrPhenotypicFeature denotes OS
T37 1373-1376 SequenceVariant denotes G/G
T38 1394-1397 SequenceVariant denotes G/A
T39 1419-1422 SequenceVariant denotes A/A
T40 1443-1453 SequenceVariant denotes IL8-251A/A
T41 1464-1470 SequenceVariant denotes rs4073
T42 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T43 1535-1541 GeneOrGeneProduct denotes VEGFR2
T44 1542-1547 SequenceVariant denotes H472Q
T45 1548-1551 SequenceVariant denotes Q/Q
T46 1562-1571 SequenceVariant denotes rs1870377
T47 1610-1615 DiseaseOrPhenotypicFeature denotes grade
T48 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T49 1766-1771 DiseaseOrPhenotypicFeature denotes PUGIT
T50 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis
T51 1807-1813 SequenceVariant denotes rs1695
T52 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T53 1890-1896 SequenceVariant denotes rs4073
T54 1901-1910 SequenceVariant denotes rs1870377
T55 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 495-509 ChemicalEntity denotes 5-fluorouracil
T18 511-515 ChemicalEntity denotes 5-FU
T19 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T20 605-609 ChemicalEntity denotes 5-FU
T21 719-723 ChemicalEntity denotes 5-FU
T22 788-792 ChemicalEntity denotes 5-FU
T23 990-998 ChemicalEntity denotes formalin
T24 1006-1014 ChemicalEntity denotes paraffin
T25 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T26 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T27 1213-1219 SequenceVariant denotes rs1695
T28 1373-1376 SequenceVariant denotes G/G
T29 1394-1397 SequenceVariant denotes G/A
T30 1419-1422 SequenceVariant denotes A/A
T31 1443-1453 SequenceVariant denotes IL8-251A/A
T32 1464-1470 SequenceVariant denotes rs4073
T33 1535-1541 GeneOrGeneProduct denotes VEGFR2
T34 1542-1547 SequenceVariant denotes H472Q
T35 1548-1551 SequenceVariant denotes Q/Q
T36 1562-1571 SequenceVariant denotes rs1870377
T37 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T38 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis
T39 1807-1813 SequenceVariant denotes rs1695
T40 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T41 1890-1896 SequenceVariant denotes rs4073
T42 1901-1910 SequenceVariant denotes rs1870377
T43 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T3 139-143 ChemicalEntity denotes 5-FU
T4 216-221 GeneOrGeneProduct denotes GSTP1
T5 223-227 GeneOrGeneProduct denotes COX2
T6 229-233 GeneOrGeneProduct denotes IL10
T7 235-239 GeneOrGeneProduct denotes EGFR
T8 246-251 GeneOrGeneProduct denotes FGFR4
T9 253-258 GeneOrGeneProduct denotes CCDN1
T10 260-266 GeneOrGeneProduct denotes VEGFR2
T11 274-279 GeneOrGeneProduct denotes CXCR2
T12 281-284 GeneOrGeneProduct denotes IL8
T13 286-290 GeneOrGeneProduct denotes MMP3
T14 292-297 GeneOrGeneProduct denotes ICAM1
T15 299-304 GeneOrGeneProduct denotes ERCC1
T16 306-311 GeneOrGeneProduct denotes RAD51
T17 317-322 GeneOrGeneProduct denotes XRCC3
T18 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T19 495-509 ChemicalEntity denotes 5-fluorouracil
T20 511-515 ChemicalEntity denotes 5-FU
T21 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T22 605-609 ChemicalEntity denotes 5-FU
T23 719-723 ChemicalEntity denotes 5-FU
T24 788-792 ChemicalEntity denotes 5-FU
T25 990-998 ChemicalEntity denotes formalin
T26 1006-1014 ChemicalEntity denotes paraffin
T27 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T28 1213-1219 SequenceVariant denotes rs1695
T29 1373-1376 SequenceVariant denotes G/G
T30 1394-1397 SequenceVariant denotes G/A
T31 1419-1422 SequenceVariant denotes A/A
T32 1443-1462 SequenceVariant denotes IL8-251A/A genotype
T33 1464-1470 SequenceVariant denotes rs4073
T34 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T35 1535-1541 GeneOrGeneProduct denotes VEGFR2
T36 1542-1560 SequenceVariant denotes H472Q Q/Q genotype
T37 1562-1571 SequenceVariant denotes rs1870377
T38 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T39 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis
T40 1807-1813 SequenceVariant denotes rs1695
T41 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T42 1890-1896 SequenceVariant denotes rs4073
T43 1901-1910 SequenceVariant denotes rs1870377
T44 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T45 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 338-359 DiseaseOrPhenotypicFeature denotes disease-free survival
T18 361-364 DiseaseOrPhenotypicFeature denotes DFS
T19 367-383 DiseaseOrPhenotypicFeature denotes overall survival
T20 385-387 DiseaseOrPhenotypicFeature denotes OS
T21 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T22 495-509 ChemicalEntity denotes 5-fluorouracil
T23 511-515 ChemicalEntity denotes 5-FU
T24 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T25 605-609 ChemicalEntity denotes 5-FU
T26 719-723 ChemicalEntity denotes 5-FU
T27 788-792 ChemicalEntity denotes 5-FU
T28 833-836 ChemicalEntity denotes DNA
T29 967-970 ChemicalEntity denotes DNA
T30 990-998 ChemicalEntity denotes formalin
T31 1006-1014 ChemicalEntity denotes paraffin
T32 1090-1093 ChemicalEntity denotes DNA
T33 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T34 1213-1219 SequenceVariant denotes rs1695
T35 1255-1258 DiseaseOrPhenotypicFeature denotes DFS
T36 1263-1265 DiseaseOrPhenotypicFeature denotes OS
T37 1326-1329 DiseaseOrPhenotypicFeature denotes DFS
T38 1334-1336 DiseaseOrPhenotypicFeature denotes OS
T39 1373-1376 SequenceVariant denotes G/G
T40 1394-1397 SequenceVariant denotes G/A
T41 1419-1422 SequenceVariant denotes A/A
T42 1443-1453 SequenceVariant denotes IL8-251A/A
T43 1464-1470 SequenceVariant denotes rs4073
T44 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T45 1535-1541 GeneOrGeneProduct denotes VEGFR2
T46 1542-1547 SequenceVariant denotes H472Q
T47 1548-1551 SequenceVariant denotes Q/Q
T48 1562-1571 SequenceVariant denotes rs1870377
T49 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T50 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis
T51 1807-1813 SequenceVariant denotes rs1695
T52 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T53 1890-1896 SequenceVariant denotes rs4073
T54 1901-1910 SequenceVariant denotes rs1870377
T55 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T56 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 59-72 SequenceVariant denotes Polymorphisms
T2 91-99 DiseaseOrPhenotypicFeature denotes Toxicity
T3 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T4 139-143 ChemicalEntity denotes 5-FU
T5 189-202 SequenceVariant denotes polymorphisms
T6 216-221 GeneOrGeneProduct denotes GSTP1
T7 223-227 GeneOrGeneProduct denotes COX2
T8 229-233 GeneOrGeneProduct denotes IL10
T9 235-239 GeneOrGeneProduct denotes EGFR
T10 246-251 GeneOrGeneProduct denotes FGFR4
T11 253-258 GeneOrGeneProduct denotes CCDN1
T12 260-266 GeneOrGeneProduct denotes VEGFR2
T13 274-279 GeneOrGeneProduct denotes CXCR2
T14 281-284 GeneOrGeneProduct denotes IL8
T15 286-290 GeneOrGeneProduct denotes MMP3
T16 292-297 GeneOrGeneProduct denotes ICAM1
T17 299-304 GeneOrGeneProduct denotes ERCC1
T18 306-311 GeneOrGeneProduct denotes RAD51
T19 317-322 GeneOrGeneProduct denotes XRCC3
T20 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T21 495-509 ChemicalEntity denotes 5-fluorouracil
T22 511-515 ChemicalEntity denotes 5-FU
T23 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T24 605-609 ChemicalEntity denotes 5-FU
T25 719-723 ChemicalEntity denotes 5-FU
T26 859-865 DiseaseOrPhenotypicFeature denotes rectal
T27 1037-1043 DiseaseOrPhenotypicFeature denotes tissue
T28 1049-1062 SequenceVariant denotes polymorphisms
T29 1196-1201 GeneOrGeneProduct denotes GSTP1
T30 1202-1211 SequenceVariant denotes Ile105Val
T31 1213-1219 SequenceVariant denotes rs1695
T32 1443-1446 GeneOrGeneProduct denotes IL8
T33 1446-1462 SequenceVariant denotes -251A/A genotype
T34 1464-1470 SequenceVariant denotes rs4073
T35 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T36 1535-1541 GeneOrGeneProduct denotes VEGFR2
T37 1542-1560 SequenceVariant denotes H472Q Q/Q genotype
T38 1562-1571 SequenceVariant denotes rs1870377
T39 1620-1675 DiseaseOrPhenotypicFeature denotes proximal upper gastrointestinal tract (PUGIT) mucositis
T40 1766-1781 DiseaseOrPhenotypicFeature denotes PUGIT mucositis
T41 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T42 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T43 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T3 117-125 OrganismTaxon denotes Patients
T4 139-143 ChemicalEntity denotes 5-FU
T5 216-221 GeneOrGeneProduct denotes GSTP1
T6 223-227 GeneOrGeneProduct denotes COX2
T7 229-233 GeneOrGeneProduct denotes IL10
T8 235-239 GeneOrGeneProduct denotes EGFR
T9 246-251 GeneOrGeneProduct denotes FGFR4
T10 253-258 GeneOrGeneProduct denotes CCDN1
T11 260-266 GeneOrGeneProduct denotes VEGFR2
T12 274-279 GeneOrGeneProduct denotes CXCR2
T13 281-284 GeneOrGeneProduct denotes IL8
T14 286-290 GeneOrGeneProduct denotes MMP3
T15 292-297 GeneOrGeneProduct denotes ICAM1
T16 299-304 GeneOrGeneProduct denotes ERCC1
T17 306-311 GeneOrGeneProduct denotes RAD51
T18 317-322 GeneOrGeneProduct denotes XRCC3
T19 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T20 495-509 ChemicalEntity denotes 5-fluorouracil
T21 511-515 ChemicalEntity denotes 5-FU
T22 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T23 605-609 ChemicalEntity denotes 5-FU
T24 719-723 ChemicalEntity denotes 5-FU
T25 788-792 ChemicalEntity denotes 5-FU
T26 866-874 OrganismTaxon denotes patients
T27 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T28 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T29 1213-1219 SequenceVariant denotes rs1695
T30 1373-1376 SequenceVariant denotes G/G
T31 1394-1397 SequenceVariant denotes G/A
T32 1419-1422 SequenceVariant denotes A/A
T33 1423-1431 OrganismTaxon denotes patients
T34 1443-1453 SequenceVariant denotes IL8-251A/A
T35 1464-1470 SequenceVariant denotes rs4073
T36 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T37 1535-1541 GeneOrGeneProduct denotes VEGFR2
T38 1542-1547 SequenceVariant denotes H472Q
T39 1548-1551 SequenceVariant denotes Q/Q
T40 1562-1571 SequenceVariant denotes rs1870377
T41 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T42 1772-1781 DiseaseOrPhenotypicFeature denotes mucositis
T43 1807-1813 SequenceVariant denotes rs1695
T44 1835-1843 OrganismTaxon denotes patients
T45 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T46 1890-1896 SequenceVariant denotes rs4073
T47 1901-1910 SequenceVariant denotes rs1870377
T48 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T49 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 91-99 DiseaseOrPhenotypicFeature denotes Toxicity
T2 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T3 117-125 OrganismTaxon denotes Patients
T4 139-143 ChemicalEntity denotes 5-FU
T5 216-221 GeneOrGeneProduct denotes GSTP1
T6 223-227 GeneOrGeneProduct denotes COX2
T7 229-233 GeneOrGeneProduct denotes IL10
T8 235-239 GeneOrGeneProduct denotes EGFR
T9 246-251 GeneOrGeneProduct denotes FGFR4
T10 253-258 GeneOrGeneProduct denotes CCDN1
T11 260-266 GeneOrGeneProduct denotes VEGFR2
T12 274-279 GeneOrGeneProduct denotes CXCR2
T13 281-284 GeneOrGeneProduct denotes IL8
T14 286-290 GeneOrGeneProduct denotes MMP3
T15 292-297 GeneOrGeneProduct denotes ICAM1
T16 299-304 GeneOrGeneProduct denotes ERCC1
T17 306-311 GeneOrGeneProduct denotes RAD51
T18 317-322 GeneOrGeneProduct denotes XRCC3
T19 338-359 DiseaseOrPhenotypicFeature denotes disease-free survival
T20 361-364 DiseaseOrPhenotypicFeature denotes DFS
T21 367-383 DiseaseOrPhenotypicFeature denotes overall survival
T22 385-387 DiseaseOrPhenotypicFeature denotes OS
T23 394-402 DiseaseOrPhenotypicFeature denotes toxicity
T24 495-509 ChemicalEntity denotes 5-fluorouracil
T25 511-515 ChemicalEntity denotes 5-FU
T26 564-578 DiseaseOrPhenotypicFeature denotes rectal cancers
T27 605-609 ChemicalEntity denotes 5-FU
T28 833-836 ChemicalEntity denotes DNA
T29 866-874 OrganismTaxon denotes patients
T30 959-970 ChemicalEntity denotes Genomic DNA
T31 1031-1036 DiseaseOrPhenotypicFeature denotes tumor
T32 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T33 1213-1219 SequenceVariant denotes rs1695
T34 1255-1258 DiseaseOrPhenotypicFeature denotes DFS
T35 1263-1265 DiseaseOrPhenotypicFeature denotes OS
T36 1373-1376 SequenceVariant denotes G/G
T37 1394-1397 SequenceVariant denotes G/A
T38 1419-1422 SequenceVariant denotes A/A
T39 1423-1431 OrganismTaxon denotes patients
T40 1443-1462 SequenceVariant denotes IL8-251A/A genotype
T41 1464-1470 SequenceVariant denotes rs4073
T42 1508-1518 DiseaseOrPhenotypicFeature denotes toxicities
T43 1535-1560 SequenceVariant denotes VEGFR2 H472Q Q/Q genotype
T44 1562-1571 SequenceVariant denotes rs1870377
T45 1620-1675 DiseaseOrPhenotypicFeature denotes proximal upper gastrointestinal tract (PUGIT) mucositis
T46 1766-1781 DiseaseOrPhenotypicFeature denotes PUGIT mucositis
T47 1849-1862 DiseaseOrPhenotypicFeature denotes rectal cancer
T48 1951-1959 DiseaseOrPhenotypicFeature denotes toxicity
T49 1978-1982 ChemicalEntity denotes 5-FU

biored-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 103-116 DiseaseOrPhenotypicFeature denotes Rectal Cancer
T2 139-143 ChemicalEntity denotes 5-FU
T3 216-221 GeneOrGeneProduct denotes GSTP1
T4 223-227 GeneOrGeneProduct denotes COX2
T5 229-233 GeneOrGeneProduct denotes IL10
T6 235-239 GeneOrGeneProduct denotes EGFR
T7 246-251 GeneOrGeneProduct denotes FGFR4
T8 253-258 GeneOrGeneProduct denotes CCDN1
T9 260-266 GeneOrGeneProduct denotes VEGFR2
T10 274-279 GeneOrGeneProduct denotes CXCR2
T11 281-284 GeneOrGeneProduct denotes IL8
T12 286-290 GeneOrGeneProduct denotes MMP3
T13 292-297 GeneOrGeneProduct denotes ICAM1
T14 299-304 GeneOrGeneProduct denotes ERCC1
T15 306-311 GeneOrGeneProduct denotes RAD51
T16 317-322 GeneOrGeneProduct denotes XRCC3
T17 495-509 ChemicalEntity denotes 5-fluorouracil
T18 547-578 DiseaseOrPhenotypicFeature denotes locally advanced rectal cancers
T19 1196-1211 SequenceVariant denotes GSTP1-Ile105Val
T20 1213-1219 SequenceVariant denotes rs1695
T21 1373-1376 SequenceVariant denotes G/G
T22 1394-1397 SequenceVariant denotes G/A
T23 1419-1422 SequenceVariant denotes A/A
T24 1443-1453 SequenceVariant denotes IL8-251A/A
T25 1464-1470 SequenceVariant denotes rs4073
T26 1535-1547 SequenceVariant denotes VEGFR2 H472Q
T27 1562-1571 SequenceVariant denotes rs1870377
T28 1666-1675 DiseaseOrPhenotypicFeature denotes mucositis
T29 1766-1781 DiseaseOrPhenotypicFeature denotes PUGIT mucositis